These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

371 related items for PubMed ID: 10440812

  • 1. Ability of yeast Ty-VLPs (virus-like particles) containing varicella-zoster virus (VZV)gE and assembly protein fragments to induce in vitro proliferation of human lymphocytes from VZV immune patients.
    Welsh MD, Harper DR, Garcia-Valcarcel M, Fowler WJ, Aitken C, Jeffries DJ, Layton GT.
    J Med Virol; 1999 Sep; 59(1):78-83. PubMed ID: 10440812
    [Abstract] [Full Text] [Related]

  • 2. Comparison of primary sensitization of naive human T cells to varicella-zoster virus peptides by dendritic cells in vitro with responses elicited in vivo by varicella vaccination.
    Jenkins DE, Yasukawa LL, Bergen R, Benike C, Engleman EG, Arvin AM.
    J Immunol; 1999 Jan 01; 162(1):560-7. PubMed ID: 9886433
    [Abstract] [Full Text] [Related]

  • 3. Equivalent recognition of a varicella-zoster virus immediate early protein (IE62) and glycoprotein I by cytotoxic T lymphocytes of either CD4+ or CD8+ phenotype.
    Arvin AM, Sharp M, Smith S, Koropchak CM, Diaz PS, Kinchington P, Ruyechan W, Hay J.
    J Immunol; 1991 Jan 01; 146(1):257-64. PubMed ID: 1670603
    [Abstract] [Full Text] [Related]

  • 4. Identification of CD8+ T cell epitopes in the immediate early 62 protein (IE62) of varicella-zoster virus, and evaluation of frequency of CD8+ T cell response to IE62, by use of IE62 peptides after varicella vaccination.
    Frey CR, Sharp MA, Min AS, Schmid DS, Loparev V, Arvin AM.
    J Infect Dis; 2003 Jul 01; 188(1):40-52. PubMed ID: 12825169
    [Abstract] [Full Text] [Related]

  • 5. Induction of neutralizing antibody and T-cell responses to varicella-zoster virus (VZV) using Ty-virus-like particles carrying fragments of glycoprotein E (gE).
    Garcia-Valcarcel M, Fowler WJ, Harper DR, Jeffries DJ, Layton GT.
    Vaccine; 1997 Jul 01; 15(6-7):709-19. PubMed ID: 9178473
    [Abstract] [Full Text] [Related]

  • 6. Recognition of the latency-associated immediate early protein IE63 of varicella-zoster virus by human memory T lymphocytes.
    Sadzot-Delvaux C, Kinchington PR, Debrus S, Rentier B, Arvin AM.
    J Immunol; 1997 Sep 15; 159(6):2802-6. PubMed ID: 9300702
    [Abstract] [Full Text] [Related]

  • 7. Identification of immunodominant regions and linear B cell epitopes of the gE envelope protein of varicella-zoster virus.
    Fowler WJ, Garcia-Valcarcel M, Hill-Perkins MS, Murphy G, Harper DR, Jeffries DJ, Burns NR, Adams SE, Kingsman AJ, Layton GT.
    Virology; 1995 Dec 20; 214(2):531-40. PubMed ID: 8553555
    [Abstract] [Full Text] [Related]

  • 8. Cloning, expression, and immunogenicity of the assembly protein of varicella-zoster virus and detection of the products of open reading frame 33.
    Garcia-Valcarcel M, Fowler WJ, Harper DR, Jeffries DJ, Layton GT.
    J Med Virol; 1997 Dec 20; 53(4):332-9. PubMed ID: 9407380
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Human T cells recognize multiple epitopes of an immediate early/tegument protein (IE62) and glycoprotein I of varicella zoster virus.
    Bergen RE, Sharp M, Sanchez A, Judd AK, Arvin AM.
    Viral Immunol; 1991 Dec 20; 4(3):151-66. PubMed ID: 1725699
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Congenital varicella-zoster virus infection and the failure to establish virus-specific cell-mediated immunity.
    Grose C.
    Mol Biol Med; 1989 Oct 20; 6(5):453-62. PubMed ID: 2560525
    [Abstract] [Full Text] [Related]

  • 15. Identification of viral antigens recognized by ocular infiltrating T cells from patients with varicella zoster virus-induced uveitis.
    Milikan JC, Kinchington PR, Baarsma GS, Kuijpers RW, Osterhaus AD, Verjans GM.
    Invest Ophthalmol Vis Sci; 2007 Aug 20; 48(8):3689-97. PubMed ID: 17652740
    [Abstract] [Full Text] [Related]

  • 16. Immunity to varicella-zoster viral glycoproteins, gp I (gp 90/58) and gp III (gp 118), and to a nonglycosylated protein, p 170.
    Arvin AM, Kinney-Thomas E, Shriver K, Grose C, Koropchak CM, Scranton E, Wittek AE, Diaz PS.
    J Immunol; 1986 Aug 15; 137(4):1346-51. PubMed ID: 3016094
    [Abstract] [Full Text] [Related]

  • 17. Antibody responses to early antigens of varicella-zoster virus (VZV) during varicella and zoster.
    Namazue J, Kato T, Yamanishi K, Takahashi M, Asano Y, Muraki R.
    Biken J; 1986 Dec 15; 29(3-4):91-7. PubMed ID: 3039973
    [Abstract] [Full Text] [Related]

  • 18. Development and validation of a gamma interferon ELISPOT assay for quantitation of cellular immune responses to varicella-zoster virus.
    Smith JG, Liu X, Kaufhold RM, Clair J, Caulfield MJ.
    Clin Diagn Lab Immunol; 2001 Sep 15; 8(5):871-9. PubMed ID: 11527795
    [Abstract] [Full Text] [Related]

  • 19. Analysis of immune function in herpes zoster patients: demonstration and characterization of suppressor cells.
    Cauda R, Grossi CE, Whitley RJ, Tilden AB.
    J Immunol; 1987 Feb 15; 138(4):1229-33. PubMed ID: 3027175
    [Abstract] [Full Text] [Related]

  • 20. Immunogenicity of a recombinant varicella-zoster virus gE-IE63 fusion protein, a putative vaccine candidate against primary infection and zoster reactivation.
    Jacquet A, Haumont M, Massaer M, Garcia L, Mazzu P, Daminet V, Grégoire D, Jacobs P, Bollen A.
    Vaccine; 2002 Feb 22; 20(11-12):1593-602. PubMed ID: 11858867
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.